Haemolytic uraemic syndrome: An overview

Nephrology

Volumn 11, Issue 3, 2006, Pages 213-218

  Amirlak, Iradj ^a   Amirlak, Bardia ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Haemolytic uraemic syndrome; Shiga toxin; Shiga toxin producing Escherichia coli; Shigella dysenteriae; Thrombotic microangiopathy

Indexed keywords

ACETYLSALICYLIC ACID; AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CALCINEURIN INHIBITOR; COMPLEMENT FACTOR H; CYANOCOBALAMIN; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FIBRIN; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; FUROSEMIDE; HEPARIN; IMMUNOGLOBULIN; PROSTACYCLIN; RAPAMYCIN; SHIGA TOXIN; SILICON DIOXIDE; STEROID; SYNSORB PK; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE KIDNEY FAILURE; ANTIPHOSPHOLIPID SYNDROME; AUTOSOMAL RECESSIVE INHERITANCE; CANADA; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DOMINANT INHERITANCE; ESCHERICHIA COLI; GASTROENTERITIS; GENETIC LINKAGE; GERMANY; HEMATOLOGY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; KIDNEY NECROSIS; NONHUMAN; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFICIENCY; REVIEW; STREPTOCOCCUS PNEUMONIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNITED STATES; VITAMIN DEFICIENCY;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; NECROSIS; PROGNOSIS;

EID: 33744814937     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00556.x     Document Type: Review

References (77)

1. Pickering LK, Obrig TG, Stapleton FB. Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli. Pediatr. Infect. Dis. J. 1994 13 : 459 75 quiz 476.
2. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 1989 262 : 355 9.
3. Constantinescu AR, Bitzan M, Weiss LS et al. Non-enteropathic hemolytic uremic syndrome: Causes and short-term course. Am. J. Kidney Dis. 2004 43 : 976 82.
4. Starr M, Bennett-Wood V, Bigham AK et al. Hemolytic-uremic syndrome following urinary tract infection with enterohemorrhagic Escherichia coli: Case report and review. Clin. Infect. Dis. 1998 27 : 310 15.
5. McLaine PN, Orrbine E, Rowe P. Childhood hemolytic-uremic syndrome in Canada: A multicenter study. In : Kaplan BS, Trommpeter RS, Moake JL eds Hemolytic-Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. New York : Marcel Dekker, 1992 61 71.
6. Gerber A, Karch H, Allerberger F et al. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study. J. Infect. Dis. 2002 186 : 493 500.
7. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int. 1995 48 : 2 19.
8. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005 19 : 1073 86.
9. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N. Engl. J. Med. 1995 333 : 364 8.
10. Bell BP, Goldoft M, Griffin PM et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 1994 272 : 1349 53.
11. Griffin PM, Ostroff SM, Tauxe RV et al. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann. Intern. Med. 1988 109 : 705 12.
12. Siegler RL. Specterum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J. Pediatr. 1994 125 : 511 18.
13. Banatvala N, Griffin PM, Greene KD et al. The United States National Prospective Hemolytic Uremic Syndrome Study: Microbiologic, serologic, clinical, and epidemiologic findings. J. Infect. Dis. 2001 183 : 1063 70.
14. van de Kar NC, Roelofs HG, Muytjens HL et al. Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur. J. Pediatr. 1996 155 : 592 5.
15. Elliott EJ, Robins-Browne RM, O'Loughlin EV et al. Nationwide study of haemolytic uraemic syndrome: Clinical, microbiological, and epidemiological features. Arch. Dis. Child. 2001 85 : 25 131.
16. Srivastava RN, Moudgil A, Bagga A, Vasudev AS. Hemolytic uremic syndrome in children in northern India. Pediatr. Nephrol. 1991 5 : 284 8.
17. Mitra AK, Rahman MM, Fuchs GJ. Risk factors and gender differentials for death among children hospitalized with diarrhoea in Bangladesh. J. Health Popul. Nutr. 2000 18 : 151 6.
18. Bhimma R, Rollins NC, Coovadia HM, Adhikari M. Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr. Nephrol. 1997 11 : 560 64.
19. Te Loo DM, van Hinsbergh VW, van den Heuvel LP, Monnens LA. Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2001 12 : 800 806.
20. Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 1992 6 : 510 12.
21. Cleary TG. The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome. Semin. Pediatr. Infect. Dis. 2004 15 : 260 65.
22. Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994 94 : 35 40.
23. Rowe PC, Orrbine E, Lior H et al. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: Results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. J. Pediatr. 1998 132 : 777 82.
24. Fitzpatrick M. Haemolytic uraemic syndrome and E. coli O157. BMJ 1999 318 : 684 5.
25. Verweyen HM, Karch H, Brandis M, Zimmerhackl LB. Enterohemorrhagic Escherichia coli infections: Following transmission routes. Pediatr. Nephrol. 2000 14 : 73 83.
26. Besser RE, Lett SM, Weber JT et al. An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA 1993 269 : 2217 20.
27. Doyle MP, Schoeni JL. Isolation of Escherichia coli O157:H7 from retail fresh meats and poultry. Appl. Environ. Microbiol. 1987 53 : 2394 6.
28. Dev VJ, Main M, Gould I. Waterborne outbreak of Escherichia coli O157. Lancet 1991 337 : 1412.
29. Carter AO, Borczyk AA, Carlson JA et al. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N. Engl. J Med. 1987 317 : 1496 500.
30. Spika JS, Parsons JE, Nordenberg D, Wells JG, Gunn RA, Blake PA. Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center. J. Pediatr. 1986 109 : 287 91.
31. Yannelli B, Domenico P, Cunha BA, Quadri SM. Nosocomial Escherichia coli O157:H7 diarrhea. Am. J. Infect. Control 1990 18 : 341 2.
32. Ruggenenti P, Remuzzi G. Pathophysiology and management of thrombotic microangiopathies. J. Nephrol. 1998 11 : 300 310.
33. Karch H, Bitzan M, Pietsch R et al. Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. Microb. Pathog. 1988 5 : 215 21.
34. Aihara Y, Nakamura T, Unayama T, Yoshida Y, Yokota S. Usefulness of serum fibrinogen degradation product-E in sporadic cases of classical hemolytic uremic syndrome. Pediatr. Int. 2000 42 : 523 7.
35. Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum. Pathol. 1988 19 : 1102 8.
36. Meyers KE, Kaplan BS. Hemolytic uremic syndrome. In : Barratt TM, Avner ED, Harmon WE eds Pediatric Nephrology, 4th edn. Baltimore : Lippincott, Williams Wilkins, 1999 811 22.
37. Neame PB, Hirsh J, Browman G et al. Thrombotic thrombocytopenic purpura: A syndrome of intravascular platelet consumption. Can. Med. Assoc. J. 1976 114 : 1108 12.
38. Ake JA, Jelacic S, Ciol MA et al. Relative nephroprotection during Escherichia coli O157:H7 infections: Association with intravenous volume expansion. Pediatrics 2005 115 : e673 80.
39. Van Dyck M, Proesmans W. Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Pediatr. Nephrol. 2004 19 : 688 90. Epub 2004 Apr 3.
40. Brunner K, Bianchetti MG, Neuhaus TJ. Recovery of renal function after long-term dialysis in hemolytic uremic syndrome. Pediatr. Nephrol. 2004 19 : 229 31.
41. Robson WL, Fick GH, Jadavji T, Leung AK. The use of intravenous gammaglobulin in the treatment of typical hemolytic uremic syndrome. Pediatr. Nephrol. 1991 5 : 289 92.
42. Perez N, Spizzirri F, Rahman R, Suarez A, Larrubia C, Lasarte P. Steroids in the hemolytic uremic syndrome. Pediatr. Nephrol. 1998 12 : 101 4.
43. Van Damme-Lombaerts R, Proesmans W, Van Damme B et al. Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: A prospective, randomized study. J. Pediatr. 1988 113 : 913 18.
44. Rousseau E, Blais N, O'Regan S. Decreased necessity for dialysis with loop diuretic therapy in hemolytic uremic syndrome. Clin. Nephrol. 1990 34 : 22 5.
45. Gianviti A, Perna A, Caringella A et al. Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome. Am. J. Kidney Dis. 1993 22 : 264 6.
46. Trachtman H, Cnaan A, Christen E et al. Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial. Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: A randomized controlled trial. JAMA 2003 290 : 1337 44.
47. Sheoran AS, Chapman S, Singh P, Donohue-Rolfe A, Tzipori S. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect. Immun. 2003 71 : 3125 30.
48. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J Med. 2000 342 : 1930 36.
49. Farquhar D. E. coli, antibiotics and hemolytic-uremic syndrome in children. CMAJ 2000 163 : 438.
50. Banatvala N, Magnano AR, Cartter ML et al. Meat grinders and molecular epidemiology: Two supermarket outbreaks of Escherichia coli O157:H7 infection. J. Infect. Dis. 1996 173 : 480 83.
51. Line JE, Fain A Jr, Moran AB. Lethality of heat to Escherichia coli O137:H7: D-value and Z-value determinations in ground beef. J. Food Prot. 1991 54 : 762 6.
52. Georgaki-Angelaki HN, Steed DB, Chantler C, Haycock GB. Renal function following acute renal failure in childhood: A long term follow-up study. Kidney Int. 1989 35 : 84 9.
53. Moghal NE, Ferreira MA, Howie AJ, Milford DV, Raafat E, Taylor CM. The late histologic findings in diarrhea-associated hemolytic uremic syndrome. J. Pediatr. 1998 133 : 220 23.
54. Small G, Watson AR, Evans JH, Gallagher J. Hemolytic uremic syndrome: Defining the need for long-term follow-up. Clin. Nephrol. 1999 52 : 352 6.
55. Garg AX, Suri RS, Barrowman N et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression. JAMA 2003 290 : 1360 70.
56. Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr. Nephrol. 2003 18 : 1095 101. Epub 2003: 17.
57. Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook JB. Atypical hemolytic-uremic syndrome: A comparison with postdiarrheal disease. J. Pediatr. 1996 128 : 505 11.
58. Neuhaus TJ, Calonder S, Leumann EP. Heterogeneity of atypical haemolytic uraemic syndromes. Arch. Dis. Child. 1997 76 : 518 21.
59. Fitzpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt TM. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J. Pediatr. 1993 122 : 532 7.
60. Kaplan BS, Proesmans W. The hemolytic uremic syndrome of childhood and its variants. Semin. Hematol. 1987 24 : 148 60.
61. Nathanson S, Deschenes G. Pneumoniae-induced hemolytic uremic syndrome. Pediatr. Nephrol. 2001 16 : 362 5.
62. Turner ME, Kher K, Rakusan T et al. Atypical hemolytic uremic syndrome in human immunodeficiency virus-1-infected children. Pediatr. Nephrol. 1997 11 : 161 3.
63. Warwicker P, Donne RL, Goodship JA et al. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency. Nephrol. Dial. Transplant. 1999 14 : 1229 33.
64. Ohali M, Shalev H, Schlesinger M et al. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr. Nephrol. 1998 12 : 619 24.
65. Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C et al. Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J. Am. Soc. Nephrol. 2004 15 : 787 95.
66. Nathanson S, Fremeaux-Bacchi V, Deschenes G. Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency. Pediatr. Nephrol. 2001 16 : 554 6.
67. Cheong HI, Lee BS, Kang HG et al. Attempted treatment of factor H deficiency by live rtransplantation. Pediatr. Nephrol. 2004 19 : 454 8.
68. Remuzzi G, Ruggenenti P, Colledan M et al. Hemolytic uremic syndrome: A fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. Am. J. Transplant. 2005 5 : 1146 50.
69. Richards A, Kemp EJ, Liszewski MK et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl. Acad. Sci. USA 2003 100 : 12966 71. Epub 2003 Oct 17.
70. Noris M, Remuzzi G. Hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2005 16 : 1035 50. Epub 2005 Feb 23.
71. Veyradier A, Obert B, Haddad E et al. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J. Pediatr. 2003 142 : 310 17. Erratum in : J. Pediatr. 2003 142 : 616.
72. Ogier de Baulny H, Gerard M, Saudubray JM, Zittoun J. Remethylation defects: Guidelines for clinical diagnosis and treatment. Eur. J. Pediatr. 1998 157 : 77 83.
73. Kind T, Levy J, Lee M, Kaicker S, Nicholson JF, Kane SA. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J. Pediatr. Hematol. Oncol. 2002 24 : 327 9.
74. Niaudet P, Gagnadoux MF, Broyer M, Salomon R. Hemolytic-uremic syndrome: Hereditary forms and forms associated with hereditary diseases. Adv. Nephrol. Necker. Hosp. 2000 30 : 261 80.
75. Kaplan BS, Leonard MB. Autosomal dominant hemolytic uremic syndrome: Variable phenotypes and transplant results. Pediatr. Nephrol. 2000 14 : 464 8.
76. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. A 12-year-old girl with hemolytic uremic syndrome as initial symptom of systemic lupus erythematosus and a literature review. Am. J. Nephrol. 2002 22 : 576 80.
77. Langer RM, Van Buren CT, Katz SM, Kahan BD. De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination. Transplantation 2002 73 : 756 60.